               AAPM REPORT NO. 263




Standardizing Nomenclatures
   in Radiation Oncology

               The Report of AAPM
                 Task Group 263
                        January 2018




 DISCLAIMER: This publication is based on sources
 and information believed to be reliable, but the
 AAPM, the authors, and the editors disclaim any war-
 ranty or liability based on or relating to the contents of
 this publication.


 The AAPM does not endorse any products, manufac-
 turers, or suppliers. Nothing in this publication should
 be interpreted as implying such endorsement.




       © 2018 by American Association of Physicists in Medicine
This page intentionally left blank.
                                     Standardizing Nomenclatures
                                        in Radiation Oncology

                              The Report of AAPM Task Group 263


Charles S. Mayo, Chair                       Susan L. Richardson                             Thomas J. Fitzgerald
University of Michigan,                      Swedish Medical Center,                         University of Massachusetts,
Ann Arbor, Michigan                          Seattle, Washington                             Worcester, Massachusetts
Jean M. Moran, Vice Chair                    Timothy Ritter                                  Andre L. Dekker
University of Michigan,                      Hunter Holmes McGuire VA Medical                Department of Radiation Oncology
Ann Arbor, Michigan                          Center, Richmond, Virginia                      (MAASTRO), GROW School for Oncology
                                                                                             and Developmental Biology, Maastricht
Walter Bosch                                 Tomasz Morgas                                   University Medical Centre+, Maastricht,
Washington University, St. Louis, Missouri   Varian Medical Systems,                         The Netherlands
                                             Palo Alto, California
Ying Xiao                                                                                    Theodore Hong
University of Pennsylvania,                  Stella Flampouri                                Massachusetts General Hospital,
Philadelphia, Pennsylvania                   University of Florida, Jacksonville, Florida    Boston, Massachusetts
Todd McNutt                                  Lakshmi Santanam                                Rishabh Kapoor
                                             Washington University, St. Louis, Missouri      Virginia Commonwealth University,
Johns Hopkins University,
Baltimore, Maryland                          Joseph A. Moore                                 Richmond, Virginia
                                             Johns Hopkins University,                       Beth Lansing
Richard Popple                               Baltimore, Maryland
University of Alabama at Birmingham,                                                         Elekta Corporation, St. Louis, Missouri
Birmingham, Alabama                          Thomas G. Purdie                                Shruti Jolly
                                             The Princess Margaret Cancer Center,
Jeff Michalski                               Toronto, ON, Canada
                                                                                             University of Michigan,
Washington University, St. Louis, Missouri                                                   Ann Arbor, Michigan
                                             Robert Miller                                   Mary E. Napolitano
Mary Feng                                    Mayo Clinic, Jacksonville, Florida
University of California San Francisco,                                                      Consultant, Suwanee, Georgia
San Francisco, California                    Coen Hurkmans                                   James Percy
                                             Catharina Hospital, Department of Radiation
Lawrence B. Marks                            Oncology, Eindhoven, The Netherlands            Elekta Corporation, St. Louis, Missouri
University of North Carolina,                                                                Mark S. Rose
Chapel Hill, North Carolina                  Judy Adams
                                             Massachusetts General Hospital,                 Sun Nuclear, Melbourne, Florida
Clifton D. Fuller                            Boston, Massachusetts                           Salim Siddiqui
MD Anderson Cancer Center,                                                                   Henry Ford Health System,
Houston, Texas                               Qing-Rong Jackie Wu
                                             Duke University, Durham, North Carolina         Detroit, Michigan
Ellen Yorke                                                                                  Christof Schadt
Memorial Sloan Kettering Cancer Center,      Colleen J. Fox
                                             Dartmouth-Hitchcock Medical Center,             Brain Lab, Chicago, Illinois
New York, New York
                                             Lebanon, New Hampshire                          William E. Simon
Jatinder Palta                               Ramon Alfredo Siochi                            Sun Nuclear Corporation,
Virginia Commonwealth University,                                                            Melbourne, Florida
                                             West Virginia University,
Richmond, Virginia
                                             Morgantown, West Virginia
                                                                                             William L. Straube
Peter E. Gabriel                             Norman L. Brown                                 Washington University, St. Louis, Missouri
University of Pennsylvania,                  Baptist Medical Center, Jacksonville, Florida
Philadelphia, Pennsylvania                                                                   Sara T. St. James
                                             Wilko Verbakel                                  University of Washington,
Andrea Molineu                               VU University Medical Center,                   Seattle, Washington
MD Anderson Cancer Center,                   Amsterdam, Netherlands
Houston, Texas                                                                               Kenneth Ulin
                                             Yves Archambault                                University of Massachusetts,
Martha M. Matuszak                           Varian Medical Systems,                         Worcester, Massachusetts
University of Michigan,                      Palo Alto, California
Ann Arbor, Michigan                                                                          Sue S. Yom
                                             Steven J. Chmura                                University of California San Francisco,
Elizabeth Covington                          University of Chicago, Chicago, Illinois        San Francisco, California
Birmingham, Alabama
                                             Don G. Eagle                                    Torunn Yock
Kathryn Masi                                 Northwest Medical Physics Center,               Massachusetts General Hospital,
Karmanos Cancer Center, Detroit, Michigan    Lynnwood, Washington                            Boston, Massachusetts
DISCLAIMER: This publication is based on sources and information believed to be reliable,
     but the AAPM, the authors, and the publisher disclaim any warranty or liability
                based on or relating to the contents of this publication.

  The AAPM does not endorse any products, manufacturers, or suppliers. Nothing in this
          publication should be interpreted as implying such endorsement.




                               ISBN: 978-1-936366-61-3
                                  ISSN: 0271-7344


               © 2018 by American Association of Physicists in Medicine

                                   All rights reserved




                                      Published by

                     American Association of Physicists in Medicine
                                  1631 Prince Street
                                Alexandria, VA 22314
                                                 THE REPORT OF AAPM TASK GROUP 263:
                                               Standardizing Nomenclatures in Radiation Oncology




                                                                        Contents

1.    Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
2.    Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
      2.1      Data Pooling . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
      2.2      Facilitating Communication During Routine Care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
      2.3      Automatic Data Extraction and Exchange. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
      2.4      Challenges Despite Some Progress . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
3.    Task Group Initiation and Membership . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
4.    Initial Evaluation of Current Nomenclature Practices . . . . . . . . . . . . . . . . . . . . 9
      4.1      Dose and Volume Units . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
      4.2      Non-Target Structure Nomenclature . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
      4.3      Nomenclature for Target Structures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
      4.4      Derived and Planning Structures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
      4.5      Vendor and DICOM Limitations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
5.    Related Standards . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
      5.1      Foundational Model of Anatomy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
      5.2      SNOMED CT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
      5.3      DICOM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
               5.3.1 DICOM Structure Interpreted Types . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
               5.3.2 DICOM Dose and Imaging Information Specification . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
               5.3.3 Other Considerations for DICOM Dose and Imaging Specification . . . . . . . . . . . . . . . . . . . . . 15
6.    Color Specification . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
7.    Recommendations for Non-Target Structure Nomenclature. . . . . . . . . . . . . . 16
      7.1      Approach . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
      7.2      Guiding Principles for Non-Target Nomenclature . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
      7.3      Structure Nomenclature List . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
8.    Recommendations for Target Structure Nomenclature . . . . . . . . . . . . . . . . . . 20
      8.1      Approach . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
      8.2      Guiding Principles for Target Nomenclature. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
9.    Recommendations for Dose Volume Histogram Metrics . . . . . . . . . . . . . . . . . 23
      9.1      Approach . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
      9.2      Guidelines for DVH Curve Metrics. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
10. Recommendations for Distinguishing Metrics of Segmented vs
    Non-Segmented Target Structures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
11. Recommendations to Vendors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
12. Nomenclature Pilot Study Design and Results. . . . . . . . . . . . . . . . . . . . . . . . . . 30
      12.1 Pilot Study Design . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
      12.2 Pilot Study Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
13.   Recommendations for Implementation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
14.   Recommendations for Clinical Trial Study Groups . . . . . . . . . . . . . . . . . . . . . . 33
15.   Recommendations for Working Group to Succeed Task Group. . . . . . . . . . . . 33
16.   Summary of Key Take-Home Points . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
17.   Acknowledgments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
18.   References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36


                                                                                  5
                                 THE REPORT OF AAPM TASK GROUP 263:
                               Standardizing Nomenclatures in Radiation Oncology




1. Introduction
The radiation oncology community can benefit from standardized nomenclatures applied to targets,
normal tissue structures, and treatment planning concepts and metrics. Such conformity enhances
safety and quality efforts within and between clinics for routine ongoing practice, and it enables data
pooling for outcomes research, registries, and clinical trials. Standardization is a vital precursor to the
development of scalable uses of scripting for quality assurance and treatment plan evaluation3,22,23.
Increased clarity and consistency through standardizing nomenclatures in these areas would provide
broad benefits.
    The charge of AAPM Task Group 263 is to provide nomenclature guidelines in radiation oncology
for use in clinical trials, data-pooling initiatives, population-based studies, and routine clinical care by
standardizing:
    1. structure names across image processing and treatment planning system platforms;
    2. nomenclature for dosimetric data (e.g., dose/volume histogram [DVH]-based metrics);
    3. templates for clinical trial groups and users of an initial subset of software platforms to facili-
       tate adoption of the standards
(Content truncated due to size limit. Use line ranges to read in chunks)